Industry-leading total Mobile and Fixed customer growth of 328,000 in the fourth quarter, driven by strong demand for our leading portfolio of bundled services across ...

TELUS Corporation today released its unaudited results for the fourth quarter of 2024. Consolidated operating revenues and other income increased by 3.5 per cent over the same period a year ago to $5.

Kalmar's financial statements review January-December 2024: Resilient profitability and strong orders in the fourth quarter Orders received increased with 20 percent and totalled EUR 486 (405) million ...

The Eastern Caribbean Currency Union (ECCU) has been providing a strong anchor for macroeconomic stability in a shock-prone region, demonstrated most recently by Hurricane Beryl with its devastating ...

CARGOTEC CORPORATION, FINANCIAL STATEMENTS REVIEW 2024, 12 FEBRUARY 2025 AT 9:00 AM (EET) Cargotec's financial statements review 2024: Successful execution of Cargotec's transformation according to ...

CARGOTEC CORPORATION, FINANCIAL STATEMENTS REVIEW 2024, 12 FEBRUARY 2025 AT 9:00 AM (EET) Cargotec's financial statements review 2024: Successful execution of Cargotec’s transformation according to pl ...

LOS ANGELES, Feb. 11, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced financial results for the fourth quarter and full year ended December 31, 2024.

Dunelm chief executive Nick Wilkinson is stepping down from the helm of the homewares retailer after seven years.

C.H. Robinson took on a more active stance with its balance sheet over the past decade, increasing leverage in part to fund opportunistic acquisitions. Before 2012, the firm was largely debt free.

This paper develops a framework to analyze partial population experiments, a generalization of the cluster experimental design where clusters are assigned to different treatment intensities. The ...

Each ADS represents four ordinary shares of Ascentage Pharma. After giving effect to the partial exercise of the over-allotment option, the total number of ADSs sold by Ascentage Pharma in the ...

Revenues beat guidance and grew year-over-year to $8.7 billion, driven by record service performance exceeding $2.0 billion, and 146 aircraft deliveries. Adjusted EBITDA (1) up 11% year-over-year to ...